Sensitive and Specific Enzyme-Linked Immunosorbent Assay Using Chemiluminescence for Detection of Severe Acute Respiratory Syndrome Viral Infection
Open Access
- 1 January 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (1), 302-310
- https://doi.org/10.1128/jcm.01006-07
Abstract
Here we report the development of a more-sensitive immunoassay for severe acute respiratory syndrome (SARS) based on an enzyme-linked immunosorbent assay using chemiluminescence (CLEIA) to detect the viral nucleocapsid (N) antigen in nasopharyngeal aspirate (NPA) from patients infected with SARS coronavirus (CoV). The CLEIA was established with an optical combination of monoclonal antibodies (MAbs) against SARS CoV N protein prepared from mice immunized with recombinant N protein without cultivating the virus. The capture and detecting MAbs of the CLEIA reacted to the carboxyl-terminal and amino-terminal peptides of the N protein, respectively. The CLEIA was capable of detecting recombinant N protein at 1.56 pg/ml and viral N protein in SARS CoV cell culture lysates at 0.087 of 50% tissue culture infective doses/ml. The CLEIA showed no cross-reactivities to recombinant N proteins of common human CoV (229E, OC43, and NL63) or lysates of cells infected with 229E and OC43. In addition, an evaluation with 18 SARS-positive NPA samples, all confirmed SARS positive by quantitative PCR and antibodies to SARS CoV, revealed that all (18/18) were found positive by the CLEIA; thus, the sensitivity of detection was 100%. When we tested 20 SARS-negative NPA samples, the CLEIA was shown to have high specificity (100%). The sensitivity of our novel SARS CLEIA was significantly higher than the previous EIA and comparable to the other methods using reverse transcription-PCR.Keywords
This publication has 44 references indexed in Scilit:
- Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISAJournal of Virological Methods, 2005
- Monoclonal Antibody-Based Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Sensitivity of the Nucleocapsid Protein in Acute-Phase Sera of Severe Acute Respiratory Syndrome PatientsClinical and Vaccine Immunology, 2005
- Mapping of Antigenic Sites on the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome CoronavirusJournal of Clinical Microbiology, 2004
- Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in SARS Patients by Enzyme-Linked Immunosorbent AssayJournal of Clinical Microbiology, 2004
- Sensitive and Specific Monoclonal Antibody-Based Capture Enzyme Immunoassay for Detection of Nucleocapsid Antigen in Sera from Patients with Severe Acute Respiratory SyndromeJournal of Clinical Microbiology, 2004
- The Epitope Study on the SARS-CoV Nucleocapsid ProteinGenomics, Proteomics & Bioinformatics, 2003
- The Structure Analysis and Antigenicity Study of the N Protein of SARS-CoVGenomics, Proteomics & Bioinformatics, 2003
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.Proceedings of the National Academy of Sciences of the United States of America, 1967
- A New Virus Isolated from the Human Respiratory Tract.Experimental Biology and Medicine, 1966